Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Ariel Focus Fund's investment thesis on Dentsply Sirona ($XRAY) — Q2 2026 | Buyside Digest

All Pitches

View Letter Analysis

$XRAYNASDAQDentsply Sirona

NEUTRAL

Ariel Focus Fund—XRAY

Fund Letter

Q2 2026

Published July 17, 2026

View Fund Profile

$13.34USD

+17.2% vs last month

$12.93Pitched

+3.1% since pitch

Market Cap$2.7B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Dentsply Sirona is undergoing a strategic turnaround to address structural pressures in its capital equipment division. The steady characteristics...

— Ariel Investments, LLC

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $XRAY, and what else Ariel Focus Fund is buying.

Other pitches on $XRAY

Other investors who've written on Dentsply Sirona

Heartland Value FundBULL

Pitched Dec 31, 2024

Despite a sharp selloff triggered by voluntary product suspension and subsequent regulatory reviews, Dentsply Sirona presents a highly compelling turnaround opportunity. The manager has...

View all $XRAY pitches →